Objective To explore the clinical epidemiological characteristics of the lung infection after orthotopical liver transplantation. Methods The clinical data included infection morbidity, mortality, infectious times and relative factors, clinical manifestations, the bacterial strains and distributions of the pathogens, the bacterial resistances of the 53 liver transplantation recipients from 2003.3~2006.12 were summarized and analyzed retrospectively. Results Among 53 recipients, 33 developed lung infectious and 6 died .The mobidity was 62.3% and mortality was 18.2%, with a OR of 1.0. Lung infection predominantly occurred in the first month, especially in the first week after transplantation.There were many factors related to lung infections.Various pathogens, especially Klebsialla, Escherichia Coli and Staphylococus Hominis were isolated from sputum, airway suction drainages and throat swabs. Most of the G- bacteria were sensitive to aminoglycosides,β lactam and lactamase compounds and carbapenems while G+ bacteria were sensitive only to glycopeptides. All the bacteria were resistant to quinolones, β lactams of third and forth generation. Conclusions After liver transplantation, the morbidity and mortality of the lung infections are high.The infections develope at earlier stage, manifest nontypical clinical features.Many factors are revealed to be relevant to the lung infections,meanwhile, various drug-resistant pathogen strains are isolated.
Citation: LIU Shuren,LUO Xiangrong,LOU Liming,YU Zhouyao,LI Zhuoliang.. The epidemiological characteristics of the lung infection after liver transplantation. Chinese Journal of Respiratory and Critical Care Medicine, 2008, 08(1): 35-39. doi: Copy
Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
-
Previous Article
Raltitrexed plus Cisplatin for Malignant Pleural Mesothelioma: A Systematic Review YANGShukun, TIAN Jinhui, YANG Kehu, YU Qin -
Next Article
Irinotecan versus Oxaplatin in Combination with 5-FU/LV for \Advanced Colorectal Cancer: A Systematic Review WANGTing, LUO Lili, ZHOU Qinghua, WU Taixiang